Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000823089 | SCV000963931 | uncertain significance | Epileptic encephalopathy | 2023-09-10 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 664907). This variant has not been reported in the literature in individuals affected with FASN-related conditions. This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 2450 of the FASN protein (p.Thr2450Met). This variant is present in population databases (rs776351410, gnomAD 0.01%). |
Ambry Genetics | RCV004619437 | SCV005113540 | uncertain significance | not specified | 2024-05-29 | criteria provided, single submitter | clinical testing | The c.7349C>T (p.T2450M) alteration is located in exon 42 (coding exon 41) of the FASN gene. This alteration results from a C to T substitution at nucleotide position 7349, causing the threonine (T) at amino acid position 2450 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |